Literature DB >> 24622761

Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.

Renan B Domingues1, T H Carvalho, D V Vassallo, S C A Domingues, A L Teixeira.   

Abstract

Cold pressure test (CPT) and mental stress test (MST) are distinct tests usually leading to blood pressure (BP) and heart rate (HR) increase. Their patterns in multiple sclerosis (MS) are still unknown. This study assessed cardiovascular reactivity to MST and CPT in patients with MS and controls. MST was performed with Stroop test card. CPT was performed with cold stimulus. The BP and HR were digitally recorded at rest and test phases. The delta (Δ) and the variance of BP and HR were compared between patients and controls. Patients with MS had lower Δ of diastolic BP and HR induced by MST than controls. There were no differences between patients and controls with CPT. The reduced autonomic reactivity to MST but not with CPT suggests that specific central nervous system pathways involved in MST may be responsible for autonomic findings in MS.

Entities:  

Mesh:

Year:  2014        PMID: 24622761     DOI: 10.1007/s10072-014-1704-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

1.  Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution?

Authors:  K Nasseri; B M Uitdehaag; M A van Walderveen; H J Ader; C H Polman
Journal:  Eur J Neurol       Date:  1999-01       Impact factor: 6.089

2.  The neurodynamics underlying attentional control in set shifting tasks.

Authors:  Anja Stemme; Gustavo Deco; Astrid Busch
Journal:  Cogn Neurodyn       Date:  2007-06-05       Impact factor: 5.082

3.  Anterior cingulate activity correlates with blood pressure during stress.

Authors:  Peter J Gianaros; Stuart W G Derbyshire; J Christopher May; Greg J Siegle; Mark A Gamalo; J Richard Jennings
Journal:  Psychophysiology       Date:  2005-11       Impact factor: 4.016

4.  Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability.

Authors:  P Flachenecker; K Reiners; M Krauser; A Wolf; K V Toyka
Journal:  Mult Scler       Date:  2001-10       Impact factor: 6.312

Review 5.  The cold pressor test: pharmacological and therapeutic aspects.

Authors:  M Velasco; J Gómez; M Blanco; I Rodriguez
Journal:  Am J Ther       Date:  1997-01       Impact factor: 2.688

6.  Heart rate variability in multiple sclerosis during a stable phase.

Authors:  J A Monge-Argilés; F Palacios-Ortega; J A Vila-Sobrino; J Matias-Guiu
Journal:  Acta Neurol Scand       Date:  1998-02       Impact factor: 3.209

7.  Progressive impairment of autonomic control of heart rate in patients with multiple sclerosis.

Authors:  Darija Mahovic; Nenad Lakusic
Journal:  Arch Med Res       Date:  2007-04       Impact factor: 2.235

8.  Altered cardiovascular reactivity to mental stress but not to cold pressure test in migraine.

Authors:  Renan B Domingues; Kelly B Fonseca; Luciene F Ziviane; Simone A Domingues; Dalton Vassalo
Journal:  Headache       Date:  2009-11-17       Impact factor: 5.887

9.  Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosis.

Authors:  M P Senaratne; D Carroll; K G Warren; T Kappagoda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

10.  Cold pressor test in the rat: medullary and spinal pathways and neurotransmitters.

Authors:  Takeshi Nakamura; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

  10 in total
  1 in total

1.  Autonomic Nervous System Response to Stressors in Newly Diagnosed Patients with Multiple Sclerosis.

Authors:  Miroslav Vlcek; Adela Penesova; Richard Imrich; Milada Meskova; Martina Mravcova; Lucia Grunnerova; Alexandra Garafova; Monika Sivakova; Peter Turcani; Branislav Kollar; Daniela Jezova
Journal:  Cell Mol Neurobiol       Date:  2017-06-21       Impact factor: 5.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.